Alternative Cancer Therapeutics: Unpatentable Compounds and Their Potential in Oncology

Area of Science:

• Oncology
• Pharmacology
• Drug Development

Background:

• Cancer is a leading global cause of death, with patients frequently seeking alternative therapies.
• Conventional cancer treatments face challenges in development time, cost, and regulatory approval rates.
• The patent system's complexity can hinder innovation in cancer drug development.

Purpose of the Study:

• To explore the potential of alternative cancer therapeutics and unconventional compounds.
• To review mechanisms and therapeutic potential of these agents as combinatorial cancer therapies.
• To demonstrate cost-effective and accessible adjuvant cancer therapy options.

Main Methods:

• Review of biological pathways and therapeutic effects of alternative cancer agents.
• Analysis of chemopreventive agents, natural products, off-patent drugs, and repurposed drugs.
• Examination of potential for enhancing existing cancer therapies.

Main Results:

• Alternative therapeutics offer potential as combinatorial cancer therapies.
• Unconventional compounds show promise in enhancing existing treatment modalities.
• Cost-effective and accessible adjuvant options are available.

Conclusions:

• Adjusting patent criteria for alternative cancer therapeutics could foster innovation.
• Alternative and repurposed drugs represent valuable, accessible options for cancer treatment.
• These approaches may improve outcomes and reduce mortality rates for cancer patients.